Purpose: Dissolution dynamic nuclear polarization (DNP) enables the acquisition of 13 C magnetic resonance data with a high sensitivity. Recently, metabolically inactive hyperpolarized 13 C-labeled compounds have shown to be potentially useful for perfusion imaging. The purpose of this study was to validate hyperpolarized perfusion imaging methods by comparing with conventional gadolinium (Gd)-based perfusion MRI techniques and pathology. 
INTRODUCTION
Glioblastoma multiforme (GBM) is the most malignant subtype of brain tumor, characterized by extreme heterogeneity, abnormal neovasculature, and active angiogenesis. Gadolinium (Gd)-based perfusion imaging methods, such as dynamic susceptibility contrast (DSC) MRI and dynamic contrast-enhanced (DCE) MRI, have been used to measure GBM blood vessel volume and permeability, and have proven to be effective in assessing changes in tumor microvasculature and response to therapy (1, 2) . Dissolution dynamic nuclear polarization (DNP) enables the acquisition of 13 C MR spectroscopic imaging (MRSI) data with a huge gain in sensitivity over conventional 13 C MR methods (3) . Recent studies using the hyperpolarized substrate [1- 13 C]pyruvate have demonstrated the promise of this technique for examining in vivo tumor metabolism in brain tumors, including differentiating tumor from normal brain tissue as well as detecting early response to treatment in animal models of high-grade glioma (4) (5) (6) (7) .
While most of the studies using hyperpolarized 13 C compounds have focused on probing metabolically active substrates and their metabolic products, metabolically inactive hyperpolarized 13 C-labeled compounds can be used for angiography and perfusion imaging (8, 9) . Recent studies using metabolically inactive 13 C-labeled hyperpolarized compounds such as [ 13 C]urea and bis-1,1-(hydroxymethyl)- [1- 13 C]cyclopropane-d 8 (HMCP) have demonstrated the feasibility of using these molecules as new perfusion MRI agents in preclinical cancer models (10, 11) . In contrast to standard Gd-based perfusion methods, the use of these hyperpolarized agents produces a signal that is directly proportional to concentration and background-free. While these prior studies showed the potential of applying metabolically inactive 13 C-labeled hyperpolarized compounds for perfusion imaging, this study was designed to directly compare the hyperpolarized perfusion imaging methods with the conventional Gd-based perfusion MRI techniques. Such a comparison will be beneficial in validating perfusion imaging with hyperpolarized agents and serve as preliminary data for the clinical translation of this technology. Dynamic 13 C imaging data using hyperpolarized HMCP were obtained from an orthotopic human GBM model for the characterization of tumor perfusion and compared with standard in vivo Gd-based DSC MRI data and immunohistochemical analysis of tissue samples from resected brains.
METHODS

Animal Preparation
Seven 6-week-old male athymic rats (rnu/rnu, homozygous, median weight ¼ 240 g) that had been purchased from Harlan (Indianapolis, IN) were used for intracranial implantation of human GBM cells (G55 MG). The details of the cell culture and intracerebral implantation procedures have been described elsewhere (4, 5) . All rats underwent 13 C and 1 H imaging on approximately the 18 th day (range: 13 th -23 rd ) after tumor cell implantation. Animal studies were approved by the Institutional Animal Care and Use Committee at our institution.
H and Hyperpolarized 13 C MRI
All animals were scanned on a 3 Tesla (T) clinical MRI system (GE Healthcare, Waukesha, WI) with 40 mT/m, 150 mT/m/ms gradients, a multinuclear spectroscopy (MNS) hardware package, and a custom-designed 1 H/ 13 C rat coil. During each imaging session, rats were placed on a heated pad positioned inside the radiofrequency (RF) coil and in the MR scanner. Anesthesia was maintained with a constant delivery of isoflurane (1-2%). Before each 13 C imaging session, high-resolution T 2 -weighted anatomical images were obtained in the axial plane using a fast spin-echo (FSE) sequence (echo time/ repetition time (TE/TR) ¼ 60/4000 ms, 8 cm field of view (FOV), 192 Â 192 matrix, 1.5 mm slice thickness and 8 number of excitations (NEX)). For each 13 C experiment, a 50 mL aqueous sample of 7.2M HMCP (T 1 ¼ 95 s ex vivo, 32 s in vivo at 3T) (8,11), 18 mM OX063 trityl radical (GE Healthcare, Oslo, Norway), and 1.5 mM Dotarem (Guerbet, Roissy, France) for polarization enhancement (12) was polarized using a HyperSense DNP polarizer (Oxford Instruments, Abingdon, UK) at 3.35T and 1.4K by irradiation with 94.1 GHz microwaves using methods described previously (3) .
After approximately 60 min of microwave irradiation, the mixture was rapidly dissolved in 5.6 mL phosphatebuffered saline, resulting in the agent having a concentration of 65 mM and pH $7.5. The level of solid state polarization achieved in this study was similar to a previous study, which used the same sample formulation for HMCP (11) . The liquid state polarization from the previous study, as measured by a low-field spectrometer, was 17-31%. A sample from the dissolved HMCP solution with volume of 2.7 mL was injected into the tail vein of the rat over a 12 s duration. At the start of the injection, dynamic images was acquired every second for 90 s using a custom designed single-slice balanced steady state free precession (bSSFP) pulse sequence (TE/ TR ¼ 6. DSC images were obtained during a second intravenous administration of 0.2 mmol/kg Gd-DTPA that used a gradient echo, echo planar imaging sequence (EPI; TE/ TR ¼ 28.2/500 ms, flip angle 35 , 8 Â 8 cm 2 in plane FOV and 40 Â 40 matrix). The bolus of Gd-DPTA was injected manually into the tail vein at 15 s after the start of data acquisition, with a total of 150 time points obtained. The scan plane prescription including in-plane origin, spatial resolution (2 Â 2 mm), and slice thickness (5.4 mm) were kept the same between hyperpolarized HMCP and DSC imaging, to allow a direct voxel-by-voxel comparison between the two methods. The first Gd-DTPA injection for the T 1 -weighted imaging served as a preload method for the subsequent DSC acquisition, which has been shown to increase the accuracy and repeatability of DSC data postprocessing and quantification (13, 14) .
Data Processing and Analysis
The methods used to process the 13 C HMCP data have been described previously (10, 11) . Dynamic HMCP images (Fig. 1a) were obtained by two-dimensional (2D) Fourier-transform of the raw HMCP data and regional magnitude HMCP signals were plotted over time (Fig.  1c) . Maximum peak signal and area under the curve were normalized by their respective values from blood vessels, which were calculated as a mean from two vascular voxels with highest signal and compared between voxels containing tumor and contralateral normal tissue using a Wilcoxon sign-rank test. The time at maximum peak signal relative to the time at peak vascular signal was calculated and compared between tumor (Dt max,tumor ) and contralateral normal tissues (Dt max,normal ) (Fig. 1c) using a Wilcoxon sign-rank test.
DSC images were processed using a previously described method (15, 16) . In short, the T2* signal time curve was converted to the change in relaxation rate (DR2*) and the peak height of this curve was calculated as the maximum DR2* signal (Fig. 2b) . Peak height values from voxels containing tumor were normalized by their respective values in normal brain tissue (nPH) and compared with both normalized maximum peak signal (nMP) and normalized area under the curve (nAUC) from the hyperpolarized HMCP data using a Pearson product-moment correlation test.
Immunohistochemistry
For immunohistochemical analysis of the vasculature, animals were euthanized after the imaging experiments. The brains were removed, fixed in phosphate-buffered 10% formalin, dehydrated by graded ethanols, and embedded in Paraplast Plus wax (McCormick Scientific, St. Louis, MO). Tissue sections were incubated with anti-a smooth muscle actin (a-SMA) antibody (Abcam, Cambridge, MA) to stain for vascular smooth muscle cells. The immunohistochemistry assays were performed on the Benchmark XT (Ventana Medical Systems, Mountain View, CA) using the UltraView detection system. The pixels with positive staining were counted from three randomly selected regions inside tumor with Â100 magnification using a threshold method in ImageJ (17) .
RESULTS
Representative data obtained with hyperpolarized HMCP imaging in GBM-bearing rats are shown in Figure 1 . Dynamic 13 C imaging allowed for the consistent measurement of hyperpolarized HMCP signal in tumor, contralateral normal brain tissue, and blood vessels with high temporal (1 s) and spatial (2 Â 2 Â 5.4 mm 3 ) resolution (Fig. 1a) . The T 1 -weighted post-Gd image in Figure  1b includes representative voxels for enhancing brain tumor (blue box), contralateral normal brain tissue (green box), and blood vessels outside the brain (red box). The time-resolved hyperpolarized 13 C imaging data were collected from throughout the rat brain for 90 s, and the dynamic curves of tumor, contralateral normal brain tissue, and blood vessel were obtained as shown in Figure 1c .
In normal brain tissue, relatively small amounts of hyperpolarized HMCP signal were observed, with high HMCP signal being detected in tumors. The signal-tonoise ratio (SNR) of the maximum peak signal and area under the curve were 22 6 6 and 563 6 152 (mean 6 SD) for contralateral brain tissue, and 32 6 10 and 974 6 331 (mean 6 SD) for tumor. The blood vessels displayed the highest HMCP signal with 88 6 38 and 2,118 6 724 (mean 6 SD) for the SNR of the maximum peak signal and area under the curve, respectively.
Representative DSC data acquired from GBM-bearing rats are shown in Figure 2 . An axial T1 post-Gd image shows enhancing tumor and the corresponding grids for DR* curves (Fig. 1a) . The mean normalized peak height was 0.94 6 0.22 (mean 6 SD) for tumor, and ranged from 0.69 to 1.25. Figure 3 compares HMCP signal characteristics between tumor, contralateral normal brain tissue, and blood vessel in seven tumor-bearing rats, showing differences that were statistically significant for various parameters. When normalized by the maximum peak signal from the reference blood vessel, the maximum peak signal (nMP) from tumor and contralateral normal tissue were 0.42 6 0.28 and 0.26 6 0.07 (mean 6 SD), respectively. nMP for tumor was higher than nMP for normal tissue in all but one animal (P < 0.04) (Fig. 3a) . The normalized area under the curve (nAUC) for tumor and normal tissue were 0.51 6 0.32 and 0.26 6 0.07 (mean 6 SD), respectively. The nAUC for tumor was higher than nAUC for normal tissue in all animals (P < 0.02) (Fig. 3b) . The hyperpolarized HMCP signal from contralateral brain tissue reached its maximum earlier than the signal from tumor and blood vessels (Fig. 1c) . The HMCP signal in contralateral normal tissue reached its maximum at 2.0 6 1.8 s (mean 6 SD) before its counterpart in blood vessels reached its maximum (Fig. 3c) . In contrast, tumor HMCP signal reached its maximum at 2.5 6 2.6 s (mean 6 SD) after its counterpart in blood vessels reached its maximum, suggesting that perfusion was delayed in tumor.
The tumor perfusion data obtained from hyperpolarized HMCP imaging were in excellent agreement with the conventional DSC imaging data. Figure 4 compares hyperpolarized HMCP dynamic data with the perfusion data that were acquired from seven GBM-bearing rats using conventional Gd-based DSC MRI. Figure 4a shows the relationship between nMP from HMCP signal from the hyperpolarized dynamic 13 C data and the nPH from DSC MRI in fifteen tumor voxels from seven rats. The total number of tumor voxels used for this analysis ranged from one to four per rat. nMP values from hyperpolarized HMCP imaging were strongly correlated with nPH values from DSC imaging when all voxels were included in analysis (p < 0.01; Fig. 4a ). This relationship also held for the mean values from each rat (p < 0.05; Fig. 4b ). The nAUC was also strongly correlated with nPH when mean values from seven rats were compared between the two modalities (p < 0.02; Fig. 4c) .
The immunohistochemical analysis of the vasculature confirmed the findings obtained from the hyperpolarized HMCP data. Figure 5 shows representative a-SMA stained slices. The rat shown in Figure 5a with a large amount of positive a-SMA staining (mean percent positive pixels ¼ 1.2 6 0.54) in tumor vascular smooth muscle cells exhibited high HMCP parameters (mean nMP ¼ 0.5, mean nAU ¼ 0.6), while the rat shown in Figure 5b with relatively small amount of staining (mean percent positive pixels ¼ 0.055 6 0.018) had smaller HMCP parameters (mean nMP ¼ 0.2, mean nAU ¼ 0.3).
FIG. 3.
A comparison of dynamic signal curve parameters from hyperpolarized HMCP data between tumor (Tumor) and contralateral brain tissue (Normal). The normalized maximum peak signal (nMP) (a), normalized area under the curve (nAUC) (b), and time at peak signal relative to time at peak vascular signal (c) showed significant differences between tumor and contralateral brain tissue.
DISCUSSION
A specialized bSSFP pulse sequence that allowed for the dynamic imaging of hyperpolarized perfusion agent HMCP with a high spatial resolution (0.022 cm 3 ) and a high temporal resolution (1 s) for orthotopic GBM xenografts was used in this study. The long T 1 relaxation time (T 1 ¼ 95 s ex vivo, 32 s in vivo at 3T) (8, 9, 11) and high polarization of HMCP enabled reliable assessment of perfusion from tumors, contralateral normal appearing brain, and vasculature with high sensitivity. The results showed distinct HMCP perfusion within the GBM tumors, with higher maximum peak signal, area under the curve, and delayed maximum signal compared with contralateral brain tissue. The elevated hyperpolarized HMCP signal that was observed in tumors can most likely be attributed to the active angiogenesis that is typically present in high-grade gliomas (18) (19) (20) .
Results from the hyperpolarized HMCP imaging were compared with data obtained using conventional Gdbased, DSC perfusion imaging to compare HMCP imaging with cerebral blood volume. The normalized maximum peak and area under the curve obtained from the hyperpolarized HMCP data in tumor were strongly correlated with normalized peak height measured from the DSC images (Fig. 4) . As the peak height from the DR2* curve in DSC images is proportional to the amount of cerebral blood volume (16), these hyperpolarized HMCP imaging parameters may represent an indirect estimate of blood volume, and provide a new method of estimating tumor perfusion with high sensitivity. The results from the immunohistochemical analysis further supported these findings by showing a high level of staining for tumor that exhibited high levels of hyperpolarized HMCP signal (Fig. 5) .
Recent studies using metabolically inactive hyperpolarized agents have demonstrated the utility of these agents for measuring tissue perfusion in vivo (10, 11, 21) . These studies used [
13 C]urea, [
13 C]HMCP, and [ 13 C]tbutanol in mouse kidney, liver, and healthy brain and have demonstrated the feasibility of monitoring permeability, perfusion, and transport in these tissues. However, hyperpolarized perfusion agents have not been applied to brain tumors or compared with gadoliniumbased dynamic perfusion MRI methods. Our current study has demonstrated the potential of using the hyperpolarized perfusion agent HMCP for regional assessment of perfusion in orthotopic GBM xenografts and was validated by findings obtained using conventional Gdenhanced DSC MRI and immunohistochemistry.
While we find this approach very promising, there are several limitations of this study. Although the proportionality of hyperpolarized HMCP signal to concentration is a theoretical advantage of HMCP perfusion imaging, signal dynamics are influenced by T1 decay and the possible variation of T1 relaxation between different tissues and across animals. The comparison of HMCP signal with Gd-enhanced DSC signal is complicated by variations in the volume, concentration and rate of injected compound between the two methods. In addition, it is very challenging to directly compare the two methods due to differences in kinetics and tissue perfusion of the
FIG. 4. Relationship between hyperpolarized
13 C HMCP and Gdenhanced DSC MRI data from tumor voxels. a: A significant correlation (p < 0.01) between the normalized maximum peak signal (nMP) from hyperpolarized HMCP data and the normalized peak height (nPH) from DSC data was observed in all 15 tumor voxels from 7 rats. Individual shapes represent data from the same animal. When mean values were calculated for each animal, nMP (b) and normalized area under the curve (nAUC) (c) from hyperpolarized HMCP data strongly correlated with nPH from DSC data for all seven rats. two agents. Due to these possible complications, we simplified our quantification methods by normalizing the signal in tumor relative to the respective values from vasculature or normal brain tissue and aimed our study to demonstrate the correlation between the two perfusion methods. The results from our data have shown the distinct HMCP signal characteristics in different tissues (Fig. 3) and the correlation between hyperpolarized HMCP and Gd-enhanced DSC perfusion parameters (Fig.  4) . The estimation of more quantitative measurements such as cerebral blood flow (CBF), cerebral blood volume (CBV), or mean transit time (MTT) may be possible; however, it is beyond the scope of this study.
Perfusion imaging using HMCP has several advantages over urea that has been used for hyperpolarized perfusion imaging in previous studies (10, 11) . HMCP has a much longer T1 compared with urea (95 s versus 47 s in solution at 3T) and crosses the blood-brain barrier (BBB) to a greater extent (21) . In contrast, urea has a limited capacity to cross BBB due to a highly polar molecular structure and the corresponding low lipid bilayer permeability (22) . While urea is an endogenous molecule and has low toxicity, the safety profile of HMCP has not been well studied and requires further investigation. No effects on heart rate or respiration were observed in our study.
In conclusion, this study has demonstrated that hyperpolarized HMCP data can be used as an indicator of tumor perfusion in an orthotopic xenograft model for GBM. The results from this study suggest that this technique may provide an alternative way to evaluate tumor perfusion for brain tumors that could be applied in patient studies.
